CAREDX ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CareDx, Inc. and Encourages Investors to Contact the Firm
Investors have until July 22, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- Investors have until July 22, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- CareDx is a diagnostics company that offers diagnostic testing services, products, and digital healthcare software for organ transplant patients and care providers.
- Additionally, the higher reimbursement payment rates for its Medicare-approved tests drove growth of the Companys average sale price (ASP), an important metric for investors.
- Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.